Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14600395rdf:typepubmed:Citationlld:pubmed
pubmed-article:14600395lifeskim:mentionsumls-concept:C1882726lld:lifeskim
pubmed-article:14600395lifeskim:mentionsumls-concept:C0020291lld:lifeskim
pubmed-article:14600395lifeskim:mentionsumls-concept:C0034307lld:lifeskim
pubmed-article:14600395lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:14600395lifeskim:mentionsumls-concept:C1440928lld:lifeskim
pubmed-article:14600395lifeskim:mentionsumls-concept:C0051655lld:lifeskim
pubmed-article:14600395lifeskim:mentionsumls-concept:C1710236lld:lifeskim
pubmed-article:14600395pubmed:issue11lld:pubmed
pubmed-article:14600395pubmed:dateCreated2003-11-5lld:pubmed
pubmed-article:14600395pubmed:abstractTextPyroglutamyl aminopeptidase I (PAP-I) is a cytosolic cysteine peptidase, which hydrolytically removes the L-pyroglutamate residue from the amino terminus of endogenous proteins and peptides. L-Pyroglutamyl p-nitroanilide serves as the synthetic substrate of this enzyme, while there is a possibility of other hydrolases being involved in the hydrolysis of this xenobiotic substrate. We cloned a full-length cDNA encoding rat PAP-I from a rat liver cDNA library and expressed this cDNA in Escherichia coli to obtain a recombinant PAP-I as a single protein. The cDNA encoded a sequence of 209 amino acids with a calculated molecular weight of 22913 Da. The homology of the deduced amino acid sequence of rat PAP-I was 98.6 and 94.3% to mouse and human PAP-Is, respectively. The biochemical properties of the recombinant rat PAP-I were almost identical to those of the recombinant mouse and human PAP-Is and the purified rat liver cytosolic PAP-I in terms of the molecular weight, subunit structure, affinity to the substrate, inhibitor profile and pH optimum. Immunoblot analysis using an antibody raised against recombinant rat PAP-I showed that rat PAP-I is present almost exclusively in the cytosolic fraction of the rat liver. Moreover, the hydrolyzing activity for L-pyroglutamyl p-nitroanilide in rat liver cytosolic fraction was completely inhibited by the antibody, strongly suggesting that this xenobiotic substrate is hydrolyzed solely by PAP-I.lld:pubmed
pubmed-article:14600395pubmed:languageenglld:pubmed
pubmed-article:14600395pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14600395pubmed:citationSubsetIMlld:pubmed
pubmed-article:14600395pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14600395pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14600395pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14600395pubmed:statusMEDLINElld:pubmed
pubmed-article:14600395pubmed:monthNovlld:pubmed
pubmed-article:14600395pubmed:issn0918-6158lld:pubmed
pubmed-article:14600395pubmed:authorpubmed-author:KnowE GEGlld:pubmed
pubmed-article:14600395pubmed:authorpubmed-author:IkedaToshihik...lld:pubmed
pubmed-article:14600395pubmed:authorpubmed-author:TokuiTaroTlld:pubmed
pubmed-article:14600395pubmed:authorpubmed-author:YamadaMakikoMlld:pubmed
pubmed-article:14600395pubmed:authorpubmed-author:WatanabeNobua...lld:pubmed
pubmed-article:14600395pubmed:authorpubmed-author:KosakaToshiyu...lld:pubmed
pubmed-article:14600395pubmed:issnTypePrintlld:pubmed
pubmed-article:14600395pubmed:volume26lld:pubmed
pubmed-article:14600395pubmed:ownerNLMlld:pubmed
pubmed-article:14600395pubmed:authorsCompleteYlld:pubmed
pubmed-article:14600395pubmed:pagination1528-33lld:pubmed
pubmed-article:14600395pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:14600395pubmed:meshHeadingpubmed-meshheading:14600395...lld:pubmed
pubmed-article:14600395pubmed:meshHeadingpubmed-meshheading:14600395...lld:pubmed
pubmed-article:14600395pubmed:meshHeadingpubmed-meshheading:14600395...lld:pubmed
pubmed-article:14600395pubmed:meshHeadingpubmed-meshheading:14600395...lld:pubmed
pubmed-article:14600395pubmed:meshHeadingpubmed-meshheading:14600395...lld:pubmed
pubmed-article:14600395pubmed:meshHeadingpubmed-meshheading:14600395...lld:pubmed
pubmed-article:14600395pubmed:meshHeadingpubmed-meshheading:14600395...lld:pubmed
pubmed-article:14600395pubmed:meshHeadingpubmed-meshheading:14600395...lld:pubmed
pubmed-article:14600395pubmed:meshHeadingpubmed-meshheading:14600395...lld:pubmed
pubmed-article:14600395pubmed:meshHeadingpubmed-meshheading:14600395...lld:pubmed
pubmed-article:14600395pubmed:meshHeadingpubmed-meshheading:14600395...lld:pubmed
pubmed-article:14600395pubmed:meshHeadingpubmed-meshheading:14600395...lld:pubmed
pubmed-article:14600395pubmed:meshHeadingpubmed-meshheading:14600395...lld:pubmed
pubmed-article:14600395pubmed:meshHeadingpubmed-meshheading:14600395...lld:pubmed
pubmed-article:14600395pubmed:year2003lld:pubmed
pubmed-article:14600395pubmed:articleTitleHydrolysis of synthetic substrate, L-pyroglutamyl p-nitroanilide is catalyzed solely by pyroglutamyl aminopeptidase I in rat liver cytosol.lld:pubmed
pubmed-article:14600395pubmed:affiliationPharmacokinetics and Drug Delivery Research Laboratories, Sankyo Co., Ltd., Hiromachi, Tokyo 140-8710, Japan. koujia@shina.sankyo.co.jplld:pubmed
pubmed-article:14600395pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:290648entrezgene:pubmedpubmed-article:14600395lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14600395lld:pubmed